{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:34:39Z","timestamp":1793756079844,"version":"4.6.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T00:00:00Z","timestamp":1473811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["094691\/Z\/10\/Z"],"award-info":[{"award-number":["094691\/Z\/10\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Epsom Medical Research","award":["TWS0114"],"award-info":[{"award-number":["TWS0114"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.neuint.2016.09.012","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T22:54:53Z","timestamp":1473720893000},"page":"110-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2+\/\u2212 mice, using liquid chromatography-tandem mass spectrometry"],"prefix":"10.1016","volume":"100","author":[{"given":"Caroline M.","family":"Forrest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.E.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Neil","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Gail","family":"Darlington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart R.","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5532-0031","authenticated-orcid":false,"given":"Trevor W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2016.09.012_bib1","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1046\/j.1471-4159.1996.66030996.x","article-title":"Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells","volume":"66","author":"Alberati-Giani","year":"1996","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2016.09.012_bib2","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1523\/JNEUROSCI.0956-07.2007","article-title":"Distinct structural and ionotropic roles of NMDA receptors in controlling spine and synapse stability","volume":"27","author":"Alvarez","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2016.09.012_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1570-0232(02)00572-X","article-title":"Quantitation of tryptophan, kynurenine and kynurenic acid in human plasma by capillary liquid chromatography-electrospray ionization tandem mass spectrometry","volume":"780","author":"Amirkhani","year":"2002","journal-title":"J.\u00a0Chromatog. B-Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.neuint.2016.09.012_bib4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1471-4159.1990.tb04553.x","article-title":"Presence of 3-hydroxyanthranilic acid in rat-tissues and evidence for its production from anthranilic acid in the brain","volume":"55","author":"Baran","year":"1990","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2016.09.012_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0165-3806(92)90256-V","article-title":"Developmental-changes in brain kynurenic acid concentrations","volume":"68","author":"Beal","year":"1992","journal-title":"Dev. Brain Res."},{"key":"10.1016\/j.neuint.2016.09.012_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0014-2999(88)90367-6","article-title":"Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor","volume":"154","author":"Birch","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2016.09.012_bib7","doi-asserted-by":"crossref","first-page":"AR16","DOI":"10.1186\/2040-2392-4-16","article-title":"Decreased tryptophan metabolism in patients with autism spectrum disorders","volume":"4","author":"Boccuto","year":"2013","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuint.2016.09.012_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/bms.1200230106","article-title":"Quantification of l-tryptophan and l-kynurenine by liquid-chromatography electron-capture negative-ion chemical-ionization mass-spectrometry","volume":"23","author":"Boni","year":"1994","journal-title":"Biol. Mass Spec."},{"key":"10.1016\/j.neuint.2016.09.012_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0563-1","article-title":"Interactions between inflammatory mediators and corticosteroids regulate transcription of genes within the kynurenine pathway in the mouse hippocampus","volume":"13","author":"Brooks","year":"2016","journal-title":"J.\u00a0Neuroinflamm"},{"key":"10.1016\/j.neuint.2016.09.012_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/schbul\/sbj052","article-title":"Prenatal infection as a risk factor in schizophrenia","volume":"32","author":"Brown","year":"2006","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuint.2016.09.012_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pneurobio.2010.09.003","article-title":"The environment and susceptibility to schizophrenia","volume":"93","author":"Brown","year":"2011","journal-title":"Progr. Neurobiol."},{"key":"10.1016\/j.neuint.2016.09.012_bib12","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1010960812204","article-title":"Changes in kynurenic, anthranilic, and quinolinic acid concentrations in rat brain tissue during development","volume":"26","author":"Cannazza","year":"2001","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2016.09.012_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jlb.45.1.29","article-title":"Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes","volume":"45","author":"Carlin","year":"1989","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.neuint.2016.09.012_bib14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1750-3639.2007.00100.x","article-title":"The neuropathology of autism","volume":"17","author":"Casanova","year":"2007","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuint.2016.09.012_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/85906","article-title":"Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice","volume":"27","author":"Chen","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2016.09.012_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/schbul\/sbl033","article-title":"Elevations of endogenous kynurenic acid produce spatial working memory deficits","volume":"33","author":"Chess","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuint.2016.09.012_bib17","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/IAI.73.8.5249-5251.2005","article-title":"Prolonged survival of a murine model of cerebral malaria by kynurenine synthesis inhibition","volume":"73","author":"Clark","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuint.2016.09.012_bib18","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1523\/JNEUROSCI.4063-04.2005","article-title":"NMDA receptor currents suppress synapse formation on sproutin axons in\u00a0vivo","volume":"25","author":"Colonnese","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2016.09.012_bib19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00004647-199907000-00007","article-title":"Kynurenine hydroxylase inhibitors reduce ischemic brain damage: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(nitrophenyl)thiazol-2YL]-benzenesulfonamide (Ro61-8048) in models of focal or global brain ischaemia","volume":"19","author":"Cozzi","year":"1999","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"key":"10.1016\/j.neuint.2016.09.012_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4137\/IJTR.S4282","article-title":"On the biological significance of the 3-hydroxyanthranilic acid:anthranilic acid ratio","volume":"3","author":"Darlington","year":"2010","journal-title":"Intern. J. Tryptophan Res."},{"key":"10.1016\/j.neuint.2016.09.012_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.nbd.2014.04.006","article-title":"Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome","volume":"68","author":"De Felice","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2016.09.012_bib22","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.brainresrev.2006.09.001","article-title":"Early brain development disruption from NMDA receptor hypofunction: relevance to schizophrenia","volume":"53","author":"du Bois","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuint.2016.09.012_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s12640-012-9354-3","article-title":"Excitotoxicity in the pathogenesis of autism","volume":"23","author":"Essa","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.neuint.2016.09.012_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1471-4159.2009.06442.x","article-title":"Blood levels of kynurenines, interleukin IL-23 and sHLA-G at different stages of Huntington's disease","volume":"112","author":"Forrest","year":"2010","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2016.09.012_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2013.01.031","article-title":"Prenatal inhibition of the tryptophan- kynurenine pathway alters synaptic plasticity and protein expression in the rat hippocampus","volume":"1504","author":"Forrest","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2016.09.012_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neuroscience.2013.09.034","article-title":"Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway","volume":"254","author":"Forrest","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2016.09.012_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuroscience.2015.09.022","article-title":"Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine","volume":"310","author":"Forrest","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2016.09.012_bib28","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpba.2015.08.026","article-title":"Quantitative analysis of phenylalanine, tyrosine, tryptophan and kynurenine in rat model for tauopathies by ultra-high performance liquid chromatography with fluorescence and mass spectrometry detection","volume":"117","author":"Galba","year":"2016","journal-title":"J.\u00a0Pharm. Biomed. Anal."},{"key":"10.1016\/j.neuint.2016.09.012_bib29","doi-asserted-by":"crossref","first-page":"36554","DOI":"10.1074\/jbc.M113.503813","article-title":"Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain","volume":"288","author":"Giorgini","year":"2013","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2016.09.012_bib30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0006-2952(75)90248-8","article-title":"Effects of hydrocortisone and immobilization on tryptophan metabolism in brain and liver of rats of different ages","volume":"24","author":"Green","year":"1975","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuint.2016.09.012_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1476-5381.1976.tb07660.x","article-title":"Tryptophan metabolism in the isolated perfused liver of the rat: effects of tryptophan concentration, hydrocortisone and allopurinol on tryptophan pyrrolase activity and kynurenine formation","volume":"57","author":"Green","year":"1976","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2016.09.012_bib32","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","article-title":"Quinolinic acid, the inescapable neurotoxin","volume":"179","author":"Guillemin","year":"2012","journal-title":"FEBS. J."},{"key":"10.1016\/j.neuint.2016.09.012_bib33","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-2-16","article-title":"Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex","volume":"2","author":"Guillemin","year":"2005","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.neuint.2016.09.012_bib34","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","article-title":"Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection","volume":"78","author":"Guillemin","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2016.09.012_bib35","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/85899","article-title":"A\u00a0mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome","volume":"27","author":"Guy","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuint.2016.09.012_bib36","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1046\/j.1460-9568.2003.02902.x","article-title":"Long-term behavioural molecular and morphological effects of neonatal NMDA receptor antagonism","volume":"18","author":"Harris","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2016.09.012_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1503\/jpn.100175","article-title":"Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls","volume":"37","author":"Holtze","year":"2012","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuint.2016.09.012_bib38","doi-asserted-by":"crossref","first-page":"12102","DOI":"10.1073\/pnas.96.21.12102","article-title":"An infection-based model of neurodevelopmental damage","volume":"96","author":"Hornig","year":"1999","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2016.09.012_bib39","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/35021059","article-title":"Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex","volume":"406","author":"Iwasato","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2016.09.012_bib40","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/ejn.12535","article-title":"Prenatal inhibition of the kynurenine pathway leads to structural changes in the hippocampus of adult rat offspring","volume":"39","author":"Khalil","year":"2014","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2016.09.012_bib41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1046\/j.1471-4159.2002.00955.x","article-title":"Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain","volume":"82","author":"Kita","year":"2002","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2016.09.012_bib42","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ab.2013.09.001","article-title":"Concurrent quantification of tryptophan and its major metabolites","volume":"443","author":"Lesniak","year":"2013","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuint.2016.09.012_bib43","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/aur.1565","article-title":"Altered kynurenine pathway metabolism in autism: implication for immune-induced glutamatergic activity","volume":"9","author":"Lim","year":"2016","journal-title":"Autism Res."},{"key":"10.1016\/j.neuint.2016.09.012_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.chroma.2016.01.023","article-title":"Targeting tryptophan and tyrosine metabolism by liquid chromatography tandem mass spectrometry","volume":"1434","author":"Marcos","year":"2016","journal-title":"J.\u00a0Chromtatog. A"},{"key":"10.1016\/j.neuint.2016.09.012_bib45","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","article-title":"Autism-like behavioral phenotypes in BTBR T+tf\/J mice","volume":"7","author":"McFarlane","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuint.2016.09.012_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062189","article-title":"The BTBR Mouse Model of autism spectrum disorders has learning and attentional impairments and alterations in acetylcholine and kynurenic acid in prefrontal cortex","volume":"8","author":"McTighe","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2016.09.012_bib47","first-page":"269","article-title":"Development of a liquid chromatography-mass spectrometry method for the determination of the neurotoxic quinolinic acid in human serum","volume":"436","author":"Meinitzer","year":"2014","journal-title":"Clin. Chim. Acta S-25"},{"key":"10.1016\/j.neuint.2016.09.012_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.pneurobio.2009.10.018","article-title":"Epidemiology-driven neurodevelopmental animal models of schizophrenia","volume":"90","author":"Meyer","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2016.09.012_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jchromb.2012.04.030","article-title":"Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma","volume":"898","author":"Moller","year":"2012","journal-title":"J.\u00a0Chromatog. B \u2013 Anal. Tech. Biomed. Life Sci."},{"key":"10.1016\/j.neuint.2016.09.012_bib50","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0021-9258(19)75845-1","article-title":"Multihormonal regulation of transcription of the tryptophan 2,3-dioxygenase gene in primary cultures of adult rat hepatocytes with special reference to the presence of a transcriptional protein mediating the action of glucocorticoids","volume":"262","author":"Nakamura","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuint.2016.09.012_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2005.07.013","article-title":"Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia","volume":"80","author":"Nilsson","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neuint.2016.09.012_bib52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ab.2011.12.032","article-title":"Gas chromatography\/tandem mass spectrometry detection of extracellular kynurenine and related metabolites in normal and lesioned rat brain","volume":"421","author":"Notarangelo","year":"2012","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuint.2016.09.012_bib53","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jpba.2015.01.030","article-title":"A\u00a0single-run liquid chromatography mass spectrometry method to quantify neuroactive kynurenine pathway metabolites in rat plasma","volume":"107","author":"Orsatti","year":"2015","journal-title":"J.\u00a0Pharm. Biomed. Anal."},{"key":"10.1016\/j.neuint.2016.09.012_bib54","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1471-4159.2008.05241.x","article-title":"Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance & neurotoxicity","volume":"105","author":"Owe-Young","year":"2008","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2016.09.012_bib55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(82)91048-4","article-title":"An iontophoretic investigation of the action of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid","volume":"247","author":"Perkins","year":"1982","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2016.09.012_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.06.016","article-title":"Modified neocortical and cerebellar protein expression and morphology following prenatal inhibition of the kynurenine pathway","volume":"1576","author":"Pisar","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2016.09.012_bib57","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/j.1460-9568.2012.08064.x","article-title":"Pre- and postnatal exposure to kynurenine causes cognitive deficits in adulthood","volume":"35","author":"Pocivavsek","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2016.09.012_bib58","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1523\/JNEUROSCI.18-19-07836.1998","article-title":"Glutamate receptor activity is required for normal development of tectal cells dendrites in\u00a0vivo","volume":"18","author":"Rajan","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuint.2016.09.012_bib59","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1523\/JNEUROSCI.21-12-04299.2001","article-title":"Suppression of cortical NMDA receptor function prevents development of orientation selectivity in the primary visual cortex","volume":"21","author":"Ramoa","year":"2001","journal-title":"J.\u00a0Neurosci."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuint.2016.09.012_bib60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ajmg.1320250530","article-title":"Preliminary brain autopsy findings in progredient Rett syndrome","volume":"25","author":"Riederer","year":"1986","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuint.2016.09.012_bib61","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1093\/brain\/awp074","article-title":"Kynurenine pathway inhibition reduces CNS inflammation in a model of human African trypanosomiasis","volume":"132","author":"Rodgers","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2016.09.012_bib62","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1021\/jm970467t","article-title":"Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl)benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase","volume":"40","author":"R\u00f6ver","year":"1997","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuint.2016.09.012_bib63","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1471-4159.1993.tb05836.x","article-title":"Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain-regions following transient cerebral-ischemia","volume":"60","author":"Saito","year":"1993","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuint.2016.09.012_bib64","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia","volume":"37","author":"Sathyasaikumar","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuint.2016.09.012_bib65","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/npp.2014.194","article-title":"Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder","volume":"40","author":"Savitz","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2016.09.012_bib66","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2016.09.012_bib67","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pneurobio.2009.04.005","article-title":"Of mice, rats and men: revisiting the quinolinic acid hypothesis of Huntington's disease","volume":"90","author":"Schwarcz","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuint.2016.09.012_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.034439","article-title":"Manipulation of brain kynurenines: glial targets neuronal effects and clinical opportunities","volume":"303","author":"Schwarcz","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuint.2016.09.012_bib69","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2217\/bmm.14.11","article-title":"Aberrant tryptophan metabolism: the unifying biochemical basis for autism spectrum disorders?","volume":"8","author":"Schwartz","year":"2014","journal-title":"Biomarkers Med."},{"key":"10.1016\/j.neuint.2016.09.012_bib70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/abio.2001.5490","article-title":"Concurrent quantification of quinolinic, picolinic, and nicotinic acids using electron-capture negative-ion gas chromatography-mass spectrometry","volume":"301","author":"Smythe","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.neuint.2016.09.012_bib71","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1503\/jpn.140126","article-title":"Increased levels of IL-6 in the cerebrospinal fluid of patients with chronic schizophrenia - significance for activation of the kynurenine pathway","volume":"40","author":"Schwieler","year":"2015","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuint.2016.09.012_bib72","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/IAI.70.2.859-868.2002","article-title":"Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in\u00a0vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1","volume":"70","author":"Silva","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuint.2016.09.012_bib73","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/bph.12230","article-title":"The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders","volume":"169","author":"Stone","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2016.09.012_bib74","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","article-title":"Quinolinic acid: a potent, endogenous excitant at amino acid receptors in CNS","volume":"72","author":"Stone","year":"1981","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2016.09.012_bib75","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrd870","article-title":"Endogenous kynurenines as targets for drug discovery and development","volume":"1","author":"Stone","year":"2002","journal-title":"Nat. Rev. Drug Disc."},{"key":"10.1016\/j.neuint.2016.09.012_bib76","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1742-4658.2012.08487.x","article-title":"Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection","volume":"279","author":"Stone","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.neuint.2016.09.012_bib77","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10882-006-9026-4","article-title":"Plasma kynurenine levels in autistic disorder","volume":"18","author":"Sweeten","year":"2006","journal-title":"J.\u00a0Dev. Phys. Disabil."},{"key":"10.1016\/j.neuint.2016.09.012_bib78","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1365\/s10337-007-0241-7","article-title":"CZE determination of quinolinic acid in rat brain tissue and plasma","volume":"65","author":"Tenorio-Lopez","year":"2007","journal-title":"Chromatographia"},{"key":"10.1016\/j.neuint.2016.09.012_bib79","doi-asserted-by":"crossref","first-page":"19553","DOI":"10.1073\/pnas.0704031104","article-title":"Regulation of spine morphology and spine density by NMDA receptor signaling in\u00a0vivo","volume":"104","author":"Ultanir","year":"2007","journal-title":"Proc. Nat. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2016.09.012_bib80","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1203\/00006450-199906000-00007","article-title":"Kynurenic acid in brain and cerebrospinal fluid of fetal newborn and adult sheep and effects of placental embolization","volume":"45","author":"Walker","year":"1999","journal-title":"Pediat Res."},{"key":"10.1016\/j.neuint.2016.09.012_bib81","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/CCM.0b013e318236f62d","article-title":"The association of the kynurenine pathway of tryptophan metabolism with acute brain dysfunction during critical illness","volume":"40","author":"Wilson","year":"2012","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.neuint.2016.09.012_bib82","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1476-5381.1981.tb10480.x","article-title":"Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrrolase by hydrocortisone: roles of tryptophan catabolism and kynurenine synthesis","volume":"74","author":"Young","year":"1981","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2016.09.012_bib83","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbi.2014.05.011","article-title":"Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: amelioration by COX-2 inhibition","volume":"41","author":"Zavitsanou","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuint.2016.09.012_bib84","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1039\/C5AY00308C","article-title":"Simultaneous determination of multiple neurotransmitters and their metabolites in rat brain homogenates and microdialysates by LC-MS\/MS","volume":"7","author":"Zhang","year":"2015","journal-title":"Anal. Methods"},{"key":"10.1016\/j.neuint.2016.09.012_bib85","doi-asserted-by":"crossref","first-page":"10044","DOI":"10.1021\/ac3025202","article-title":"Quantitative analysis of neurochemical panel in rat brain and plasma by liquid chromatography-tandem mass spectrometry","volume":"84","author":"Zheng","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.neuint.2016.09.012_bib86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.pediatrneurol.2005.03.014","article-title":"Cerebrospinal fluid and serum markers of inflammation in autism","volume":"33","author":"Zimmerman","year":"2005","journal-title":"Ped. Neurol."},{"key":"10.1016\/j.neuint.2016.09.012_bib87","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/npp.2011.277","article-title":"Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis","volume":"37","author":"Zunszain","year":"2012","journal-title":"Neuropsychopharmacology"}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018616301681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018616301681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T05:45:16Z","timestamp":1657259116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018616301681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":87,"alternative-id":["S0197018616301681"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2016.09.012","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2+\/\u2212 mice, using liquid chromatography-tandem mass spectrometry","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2016.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}